News and blog posts
09
Dec 2019
Since autumn 2019, MTRC started the release of the Market Access Magazine with an overview of key reimbursement news for the last quarter, along with analytical reviews on the topic of market access for medical technologies (reimbursement, funding, HTA, innovation payment schemes). Download free of charge from our website.
Read more
05
Dec 2019
In late October 2019, the DIMDI (German Institute of Medical Documentation and Information) has published the final version of the OPS 2020 (Operation and Procedure Keys). The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification) forms the basis for the reimbursement systems in outpatient and inpatient care.
Read more
04
Dec 2019
In November 2019, the two new mini-method assessments for ankyloglossia and rapid testing for chlamydia and gonorrhea were initiated by Oslo University. After the completion of the assessment procedure, the final reports would be available via a mini-HTA database.
Read more
Scientific evidence on personalized population screening for breast cancer assessed by Spanish AQuAS
03
Dec 2019
In October 2019, the Agency for Health Quality and Assessment of Catalonia (AQuAS) has released an assessment report regarding the scientific evidence on personalized population screening for breast cancer. The current evidence does not allow to recommend any concrete models for individualized risk prediction for breast cancer but allows to recommend the development and evaluation of new models for personalized risk prediction directed to offering different strategies to the screening of population.
Read more
03
Dec 2019
In October 2019, the National Institute for Health and Care Excellence (NICE) published one new interventional procedure guidance (for midcarpal hemiarthroplasty for wrist arthritis) and two new MedTech innovation briefings (for superDimension Navigation System to help diagnostic sampling of peripheral lung lesions and MR-proADM test for use with clinical deterioration scores in cases of suspected infection).
Read more
02
Dec 2019
The National disease management guideline for chronic heart failure with recommendations for diagnostics and therapy has been revised. It is now available free of charge on the internet pages of the Medical Center for Quality in Medicine.
Read more
29
Nov 2019
On September 16, 2019, the Nomenclature was updated. The update brought changes in chapter V of Nomenclature, regarding the creation of new codes and modification of existing codes.
Read more
28
Nov 2019
MTRC is looking for a Chinese analyst to join our team. The responsibilities will include development and maintaining overviews of reimbursement systems in China and other Asian countries, development of reimbursement analysis, collection of cost data, payor and KOL interviews.
Read more
28
Nov 2019
MTRC is looking for an Arab-speaking analyst to join our team. The responsibilities will include development and maintaining overviews of reimbursement systems in the Middle East countries, development of reimbursement analysis, collection of cost data, payor and KOL interviews.
Read more
27
Nov 2019
On behalf of the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether wearing a lower jaw protrusion splint (Unterkieferprotrusionsschiene, UPS) is beneficial for obstructive sleep apnea.
Read more
26
Nov 2019
In October 2019, the Agency for Health Quality and Assessment of Catalonia (AQuAS) has released an assessment report regarding the evaluation of Сerenkov luminescence image projection system for intraoperative evaluation of surgical margins in breast, prostate and gastrointestinal cancer. This new technology is expected to get an improvement in the effectiveness of oncological surgery and a reduction in costs.
Read more
25
Nov 2019
The New Therapies (NT) Council provides comments on medical technology products and methods that are evaluated within the framework of the Dental and Pharmaceutical Benefits Agency (TLV) medical technology assignment. In October 2019, the NT Council recommended the use of FoundationOne CDx comprehensive genomic profiling test as support for the drug treatment choice in the context of clinical studies as there is a great need for knowledge and validation.
Read more